These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 16304396)

  • 1. Clinical presentation and management of marginal zone lymphomas.
    Thieblemont C
    Hematology Am Soc Hematol Educ Program; 2005; ():307-13. PubMed ID: 16304396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of marginal zone lymphomas.
    Thieblemont C; Coiffier B
    Curr Treat Options Oncol; 2006 May; 7(3):213-22. PubMed ID: 16615877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.
    Olszewski AJ; Castillo JJ
    Cancer; 2013 Feb; 119(3):629-38. PubMed ID: 22893605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marginal zone lymphomas: management of nodal, splenic, and MALT NHL.
    Kahl B; Yang D
    Hematology Am Soc Hematol Educ Program; 2008; ():359-64. PubMed ID: 19074110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
    Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
    Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
    Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
    Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
    Nathwani BN; Anderson JR; Armitage JO; Cavalli F; Diebold J; Drachenberg MR; Harris NL; MacLennan KA; Müller-Hermelink HK; Ullrich FA; Weisenburger DD
    J Clin Oncol; 1999 Aug; 17(8):2486-92. PubMed ID: 10561313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.
    Traverse-Glehen A; Baseggio L; Salles G; Felman P; Berger F
    Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Marginal zone lymphomas: extranodal MALT type, nodal and splenic].
    Dallenbach FE; Coupland SE; Stein H
    Pathologe; 2000 Mar; 21(2):162-77. PubMed ID: 10840821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary nodal marginal zone lymphomas of splenic and MALT type.
    Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic marginal zone lymphoma: current knowledge and future directions.
    Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
    Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marginal zone B-cell lymphomas.
    Sagaert X; Tousseyn T
    Discov Med; 2010 Jul; 10(50):79-86. PubMed ID: 20670602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary management of nodal and primary splenic marginal zone lymphoma.
    Leslie LA; Feldman TA; McNeill A; Timberg M; Iida H; Goy AH
    Expert Rev Hematol; 2019 Dec; 12(12):1011-1022. PubMed ID: 31619091
    [No Abstract]   [Full Text] [Related]  

  • 14. [Splenic marginal zone B-cell lymphoma with epidermotropic skin involvement].
    Gómez-de la Fuente E; Villalón LB; Calzado-Villarreal L; Pinedo-Moraleda F; López-Estebaranz JL
    Actas Dermosifiliogr; 2012 Jun; 103(5):427-31. PubMed ID: 21885023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites.
    Kuper-Hommel MJ; van de Schans SA; Vreugdenhil G; van Krieken JH; Coebergh JW
    Leuk Lymphoma; 2013 Sep; 54(9):1891-7. PubMed ID: 23302044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of the marginal zone lymphomas.
    Vannata B; Stathis A; Zucca E
    Cancer Treat Res; 2015; 165():227-49. PubMed ID: 25655612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients.
    Berger F; Felman P; Thieblemont C; Pradier T; Baseggio L; Bryon PA; Salles G; Callet-Bauchu E; Coiffier B
    Blood; 2000 Mar; 95(6):1950-6. PubMed ID: 10706860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The many faces of marginal zone lymphoma.
    Zinzani PL
    Hematology Am Soc Hematol Educ Program; 2012; 2012():426-32. PubMed ID: 23233614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective management strategies for patients with marginal zone lymphoma.
    Rosand CB; Valla K; Flowers CR; Koff JL
    Future Oncol; 2018 May; 14(12):1213-1222. PubMed ID: 29260925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.